TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 4,535.00
-5.00 (-0.11%)
At close: Aug 12, 2025, 3:30 PM KST
TiumBio Revenue
TiumBio had revenue of 2.11B KRW in the quarter ending March 31, 2025, with 5.76% growth. This brings the company's revenue in the last twelve months to 6.91B, up 3.24% year-over-year. In the year 2024, TiumBio had annual revenue of 6.79B with 38.65% growth.
Revenue (ttm)
6.91B
Revenue Growth
+3.24%
P/S Ratio
18.64
Revenue / Employee
101.57M
Employees
68
Market Cap
128.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.79B | 1.89B | 38.65% |
| Dec 31, 2023 | 4.90B | -4.22B | -46.27% |
| Dec 31, 2022 | 9.12B | 9.06B | 15,952.75% |
| Dec 31, 2021 | 56.80M | -992.15M | -94.59% |
| Dec 31, 2020 | 1.05B | -64.05M | -5.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| KB Financial Group | 15.69T |